Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
13.68
+0.37 (2.78%)
At close: Jun 27, 2025, 4:00 PM
13.68
0.00 (0.00%)
After-hours: Jun 27, 2025, 4:34 PM EDT
Ardent Health Stock Forecast
Stock Price Forecast
According to 13 professional analysts, the 12-month price target for Ardent Health stock ranges from a low of $18 to a high of $25. The average analyst price target of $20.77 forecasts a 51.83% increase in the stock price over the next year.
Price Target: $20.77 (+51.83%)
Analyst Consensus: Buy
* Price targets were last updated on May 20, 2025.
Analyst Ratings
The average analyst rating for Ardent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 6 | 7 | 7 | 7 | 7 | 7 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $21 | Buy | Reiterates | $21 | +53.51% | May 20, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +53.51% | May 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | +31.58% | May 9, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +16.96% | Apr 9, 2025 |
| Mizuho | Mizuho | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +31.58% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
6.46B
from 5.97B
Increased by 8.25%
Revenue Next Year
6.82B
from 6.46B
Increased by 5.56%
EPS This Year
1.95
from 1.58
Increased by 23.69%
EPS Next Year
2.08
from 1.95
Increased by 6.21%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.7B | 7.1B | 7.5B |
| Avg | 6.5B | 6.8B | 7.2B |
| Low | 6.2B | 6.5B | 6.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 12.1% | 9.6% | 9.6% |
| Avg | 8.2% | 5.6% | 5.4% |
| Low | 3.7% | 0.8% | 0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.11 | 2.44 | 2.71 |
| Avg | 1.95 | 2.08 | 2.30 |
| Low | 1.82 | 1.80 | 1.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 33.6% | 24.6% | 30.5% |
| Avg | 23.7% | 6.2% | 10.8% |
| Low | 15.4% | -7.7% | -4.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.